Sign In

Rajesh Gupta

Developing therapeutics and vaccines for global infectious diseases

Rajesh Gupta is a highly accomplished professional with over 20 years of experience in global infectious diseases, focusing on a wide range of pathogens like HIV, TB, malaria, and coronaviruses. His expertise includes portfolio strategy, regulatory approvals, fundraising, partnership development, and program implementation. He has a strong background in leading cross-functional teams, conducting clinical trials, and contributing to scientific publications. Rajesh holds a diverse educational background, including a Doctor of Medicine from Stanford University School of Medicine and degrees from Yale School of Medicine and Tulane University.

Highlights

May 2 · Yahoo Finance
Vir Biotechnology Receives Expanded Support to Develop Its Novel T Cell Vaccine Platform with New $10 Million Grant for HIV Prevention - Yahoo Finance
Vir Biotechnology Receives Expanded Support to Develop Its Novel T Cell Vaccine Platform with New $1
May 2 · GlobeNewswire
Vir Biotechnology Receives Expanded Support to Develop Its Novel ... - GlobeNewswire
Vir Biotechnology Receives Expanded Support to Develop Its Novel ... - GlobeNewswire
Rajesh Gupta
Add to my network

Location

San Francisco Bay Area